Metabolites from marine fungi have hogged the limelight in drug discovery because of their
promise as therapeutic agents. A number of metabolites related to marine fungi have been …

The human immunodeficiency virus (HIV) is responsible for acquired immune deficiency
syndrome (AIDS), one of the major pandemic diseases. Highly active antiretroviral therapy …

The implementation of nanomedicine in cellular, preclinical, and clinical studies has led to
exciting advances ranging from fundamental to translational, particularly in the field of …

Antiretroviral therapies efficiently block HIV-1 replication but need to be maintained for life.
Moreover, chronic inflammation is a hallmark of HIV-1 infection that persists despite …

The therapeutic efficacy of antiretroviral drugs as well as challenges and side effects against
the human immunodeficiency virus is well documented and reviewed. Evidence is available …

Long-term delivery of anti-HIV monoclonal antibodies (mAbs) using adeno-associated virus
(AAV) vectors holds promise for the prevention and treatment of HIV infection. We describe a …

Abstract 35 years since identification of HIV as the causative agent of AIDS, and 35 million
deaths associated with this disease, significant effort is now directed towards the …

For human immunodeficiency virus (HIV)-infected patients, the 1990s were marked by the
introduction of highly active antiretroviral therapy (HAART) representing a new perspective …

The persistence of latent HIV proviruses in long-lived CD4+ T cells despite antiretroviral
therapy (ART),, is a major obstacle to viral eradication,,. Because current candidate latency …

Although a number of PCR-based quantitative assays for measuring HIV-1 persistence
during suppressive antiretroviral therapy (ART) have been reported, a simple, sensitive …